Where does NovaSignal Corp. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), NovaSignal Corp. ranks #14,822 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does NovaSignal Corp. hold?

NovaSignal Corp. holds 20 US utility patents granted between 2020 and 2023, spanning 14 technology areas.

What is NovaSignal Corp.'s Innovation Score?

NovaSignal Corp. has an Innovation Score of 50.9 out of 100 (top 12% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does NovaSignal Corp. focus on?

NovaSignal Corp.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 19 patents, ranking #930 of 7,127 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

Is NovaSignal Corp.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for NovaSignal Corp..

What does claim depth mean for NovaSignal Corp.'s patents?

NovaSignal Corp.'s patents average 19.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the NovaSignal Corp. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

NovaSignal Corp.

USPTO PatentsView assignee record - 20 granted patents across 14 technology areas, recorded in grant years 2020–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Novasignal ranks #14,822 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 14 technology areas.

#14,822
of 49,997 US assignees by volume: Top 12%
by Innovation Score (50.9/100): 19.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R14822 · US Corporation #14,822 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 20 grants
MID-PACK #14,822/49,997
PHOTO-FINISH Nocion Therapeutics
CPC-FOCUS A61B · 14 areas
INNOV-PAR 50.9/100
CLAIMS-RICH 19.4 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2023 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Nocion Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Novasignal’s 50.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (21%) Velocity 15.6 pts (31%) Breadth 13.2 pts (26%) Claim depth 11.6 pts (23%)

Qualcomm Incorporated · highest

85
NovaSignal · this assignee

51
3D Lighting… · lowest

7

What this shows Novasignal's Innovation Score is 50.9/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Novasignal?

Each dot is one of Novasignal’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Novasignal’s own 19.4 claims/patent is ABOVE the 14.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Novasignal vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Novasignal's grants concentrate

NovaSignal Corp. is a focused PatentsView assignee: 14 CPC subclasses with 95% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (8 grants) versus a trough of 1 in 2020. By volume, Novasignal sits between Nocion Therapeutics, Inc. and ONE Test Systems.

Novasignal's three-year grant acceleration

NovaSignal Corp. shows 14 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nocion Therapeuti…

20
Norsk Titanium AS

20
Norwood Architect…

20
Nova Southeastern…

20
Nuseed Pty

20
Oclu

20
Ondavia

20
ONE Test Systems

20
Novasignal ◀

20

What this shows NovaSignal holds 20 patents at rank #14,819, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near NovaSignal

By rank, the assignees closest to #14,819 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in NovaSignal's primary technology class.

Novasignal's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

NovaSignal Corp. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	5.0%
2021	5	25.0%
2022	6	30.0%
2023	8	40.0%

Which technologies does NovaSignal Corp. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 19

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 5

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 3

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 3

A45D - Hairdressing OR Shaving Equipment ; Equipment FOR Cosmetics OR Cosmetic Treatments, e.g. FOR Manicuring OR Pedicuring 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

H04N - Pictorial Communication, e.g. Television 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

G06F - Electric Digital Data Processing 1

A42B - HATS; Head Coverings 1

H04R - Loudspeakers, Microphones, Gramophone Pick-ups OR Like Acoustic Electromechanical TRANSDUCERS; Deaf-aid SETS; Public Address Systems 1

A47C - CHAIRS; SOFAS; Beds 1

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 1

G01S - Radio DIRECTION-FINDING; Radio NAVIGATION; Determining Distance OR Velocity BY USE OF Radio WAVES; Locating OR Presence-detecting BY USE OF THE Reflection OR Reradiation OF Radio WAVES; Analogous Arrangements Using Other Waves 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

NovaSignal Corp.'s patent record in context - here's where to go next.

NovaSignal Corp.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 95% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #14,822 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare NovaSignal Corp. against Nocion Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.